In Vitro Evaluation of an Adhesive Hydrogel‐Based Chondrocyte Carrier for Enhanced Therapeutic Delivery
Macromolecular Bioscience · 2026-04 · 26 (4)
DOI: 10.1002/mabi.202500653 ↗At a glance
Journal article in Macromolecular Bioscience, published online on 2026-04-09. Written by Peyman Karami and 5 co-authors. Institution: Department of Orthopedic Surgery and Traumatology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. Major MEDLINE topics: Chondrocytes, Hydrogels. 22 references. The full text is freely available (open access, CC BY 4.0). Funded by: Swiss Innovation Agency (Innosuisse).
Abstract (original language)
Large knee chondral defects remain a major challenge in orthopaedic surgery and may lead to osteoarthritis. Autologous chondrocyte implantation (ACI) is a widely used regenerative therapy; current techniques have inherent limitations related to cell delivery, retention, and integration. This study investigates a novel adhesive hydrogel as a cell carrier for enhanced therapeutic delivery in cartilage repair. This injectable hydrogel can lead to a paradigm shift in ACI through removing the need for membranes entirely and enabling direct in situ fixation of cell‐laden constructs while preserving the chondrocytic phenotype. In this work, we report in vitro encapsulation of human autologous chondrocytes (HACs) using cells from five orthopedic patients within this hydrogel with subsequent in vitro evaluation of functional outcomes, including cell viability, glycosaminoglycan production, histological and immunohistological outcomes, and evolution of mechanical properties of the cell constructs. Moreover, by analyzing the hydrogel polymer content (PC), we identified an optimal formulation balancing biological activity and mechanical integrity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Orthopedic Surgery and Traumatology, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
- Laboratory of Biomechanical Orthopaedics, Institute of Bioengineering, School of Engineering, EPFL, Lausanne, Switzerland.
- Manufacturing Department, LAM Biotechnologies SA, Epalinges, Switzerland.
- Regenerative Therapy Unit, Reconstructive and Hand Surgery Service, Lausanne University Hospital, University of Lausanne, Epalinges, Switzerland.
- Center For Applied Biotechnology and Molecular Medicine, University of Zurich, Zurich, Switzerland.
- Oxford OSCAR Suzhou Center, Oxford University, Suzhou, China.
ORCID profiles: Peyman Karami, Dominique P Pioletti, Robin Martin
Funding
- Swiss Innovation Agency (Innosuisse)
Cite
APA
Karami, P., Laurent, A., Philippe, V., Applegate, L. A., Pioletti, D. P., & Martin, R. (2026). In Vitro Evaluation of an Adhesive Hydrogel‐Based Chondrocyte Carrier for Enhanced Therapeutic Delivery. Macromolecular Bioscience, 26(4). https://doi.org/10.1002/mabi.202500653
Vancouver
Karami P, Laurent A, Philippe V, Applegate LA, Pioletti DP, Martin R. In Vitro Evaluation of an Adhesive Hydrogel‐Based Chondrocyte Carrier for Enhanced Therapeutic Delivery. Macromolecular Bioscience. 2026;26(4). doi:10.1002/mabi.202500653
BibTeX
@article{Karami2026,
author = {Karami, Peyman and Laurent, Alexis and Philippe, Virginie and Applegate, Lee Ann and Pioletti, Dominique P and Martin, Robin},
title = {In Vitro Evaluation of an Adhesive Hydrogel‐Based Chondrocyte Carrier for Enhanced Therapeutic Delivery},
journal = {Macromolecular Bioscience},
year = {2026},
volume = {26},
number = {4},
doi = {10.1002/mabi.202500653}
}
EUVIMED